No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
278 |
4. Check minimum number of eventsNone |
278 |
5. Include endpointsNone |
278 |
6. Filter based on genotype QC (FinnGen only) |
278 |
Control definitions (FinnGen only)
- Control exclude
- M13_SOFTTISSUE
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M62
- Name in latin
- Diastasis musculi
Similar endpoints
↥List of similar endpoints to
Diastasis of muscle
based on the number of shared cases.
Similar with more cases:
- Disorders of muscles
- Soft tissue disorders
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1432 | 834 | 588 |
| Only index persons | 1376 | 813 | 563 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.02 |
| Only index persons | 0.03 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 48.12 | 41.83 | 57.15 |
| Only index persons | 48.03 | 41.56 | 57.37 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 278 | 183 | 95 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.04 |
| Median age at first event (years) | 49.47 | 43.45 | 61.05 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 237
- Matched controls
- 2371
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M62.0
ICD-10 Finland
Diastasis of muscle
+∞
323.0
237
*
QBJ30
NOMESCO Finland
Correction of abdominal apron
674.1
56.0
53
*
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
21.6
38.8
58
35
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
17.0
28.6
46
33
JAG96
NOMESCO Finland
Other reconstruction of abdominal wall
253.5
23.0
23
*
N02AX02
ATC
tramadol; systemic, rectal
3.8
20.6
122
514
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.3
16.0
113
515
M79.6
ICD-10 Finland
Pain in limb
3.8
15.9
81
286
N02BE01
ATC
paracetamol; systemic, rectal
4.7
14.9
216
1622
N03AX12
ATC
gabapentin; oral
5.0
13.4
45
106
JN3AD
NOMESCO Finland
Abdominal CT examination
6.4
12.8
34
60
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.1
11.6
76
314
S18
ICPC
Laceration/cut
2.7
11.1
100
505
A02BC02
ATC
pantoprazole; systemic
2.6
10.8
154
995
M19.0
ICD-10 Finland
Primary arthrosis of other joints
6.5
10.5
27
46
M54.5
ICD-10 Finland
Low back pain
2.7
10.4
91
447
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
42.0
10.1
12
*
JAF10
NOMESCO Finland
Repair of umbilical hernia
11.4
10.0
18
17
JAG60
NOMESCO Finland
Reconstruction of abdominal wall using prosthetic material
104.0
9.5
10
*
O30.0
ICD-10 Finland
Twin pregnancy
10.2
9.4
18
19
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.1
9.2
36
99
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.4
9.0
107
611
R51.80
ICD-10 Finland
Headache
3.3
8.7
47
165
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.3
8.5
110
645
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
+∞
8.4
8
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
5.4
8.3
24
48
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.9
8.3
53
211
Z01.8
ICD-10 Finland
Other specified special examinations
2.8
8.1
58
247
SPAT1262
SPAT
Handing over of treatment supplies
3.1
8.0
46
171
G47.3
ICD-10 Finland
Sleep apnoea
2.7
8.0
60
262
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.6
8.0
69
328
J01DB01
ATC
cefalexin; oral
2.6
7.7
199
1588
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.1
7.7
44
163
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.1
7.7
44
164
N03AX16
ATC
pregabalin; oral
2.8
7.6
53
222
SPAT1249
SPAT
Treatment-related counselling outside office
2.2
7.6
106
637
L03
ICPC
Low back symptom/complaint
2.6
7.5
62
286
A02BC05
ATC
esomeprazole; systemic
2.3
7.4
93
528
J01AA02
ATC
doxycycline; systemic
2.3
7.4
183
1407
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
+∞
7.3
7
*
L57.4
ICD-10 Finland
Cutis laxa senilis
+∞
7.3
7
*
M79.1
ICD-10 Finland
Myalgia
3.6
7.3
33
103
M65.3
ICD-10 Finland
Trigger finger
16.4
7.3
11
7
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.4
7.2
18
30
E66.8
ICD-10 Finland
Other obesity
4.6
7.2
24
57
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.6
7.2
32
99
R03AC02
ATC
salbutamol; inhalant
2.1
7.0
126
836
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
2.9
7.0
46
184
SPAT1263
SPAT
Sampling
2.1
6.9
109
684
J01FA10
ATC
azithromycin; systemic
2.1
6.9
140
973
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
6.8
35
121
M79.0
ICD-10 Finland
Rheumatism, unspecified
23.3
6.7
9
*
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
6.7
87
502
SPAT1153
SPAT
Removal of sutures
2.3
6.7
72
382
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
6.6
88
513
T90
ICPC
Diabetes non-insulin dependent
2.5
6.5
53
243
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.1
6.5
36
129
UJF32
NOMESCO Finland
Coloscopy
2.4
6.5
59
286
SFA10
NOMESCO Finland
Fillning on one surface of tooth
2.0
6.5
132
909
M79.7
ICD-10 Finland
Fibromyalgia
14.8
6.5
10
7
H02AB06
ATC
prednisolone; systemic
2.1
6.4
103
644
A10BA02
ATC
metformin; oral
2.3
6.4
65
333
N06AX21
ATC
duloxetine; oral
3.6
6.3
27
81
K42
ICD-10 Finland
Umbilical hernia
18.6
6.3
9
5
SPAT1310
SPAT
Counselling related to known health issue
2.2
6.3
78
436
4211
FHL
Transeptal septal resection and reconstruction
27.5
6.3
8
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.7
6.2
43
180
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
2.0
6.2
123
832
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
6.2
65
337
J01FF01
ATC
clindamycin; systemic
2.3
6.0
64
334
R01AD09
ATC
mometasone; nasal
2.0
6.0
112
740
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
120
591
2.81
15.51
3.0
2.2
56.8
56.0
u/l
0.05
109
552
170
1033
2.66
14.01
4.9
4.0
—
—
—
0
0
161
1011
2.41
11.53
5.8
6.5
10.4
11.3
umol/l
0.77
150
956
54
202
3.08
11.18
4.1
2.8
—
—
—
0
0
177
1174
2.40
10.98
4.9
4.6
6.6
6.6
mmol/l
0.11
160
1072
137
837
2.26
10.02
4.6
3.4
—
—
—
0
0
100
546
2.30
9.48
5.0
3.6
0.0
0.0
estimate
0.50
39
210
158
1048
2.18
9.14
4.6
3.2
0.0
0.0
estimate
0.00
42
212
158
1058
2.14
8.80
5.7
4.5
0.0
0.0
estimate
0.50
41
216
266
2255
5.16
8.72
17.4
12.3
139.6
139.6
mmol/l
0.07
261
2192
16
29
5.79
8.60
2.2
2.5
16.7
17.3
%
—
8
15
158
1067
2.11
8.50
4.6
3.3
0.0
0.0
estimate
0.00
42
203
266
2263
5.06
8.49
17.6
12.4
3.9
3.9
mmol/l
0.15
261
2194
129
808
2.11
8.47
4.8
4.6
36.1
36.2
g/l
0.03
119
756
212
1612
2.33
8.33
7.3
6.9
72.1
78.2
u/l
1.66
203
1512
223
1740
2.42
8.12
4.6
3.9
14.6
14.4
pmol/l
0.39
200
1599
114
693
2.09
7.99
4.5
3.3
19.8
35.5
ng/l
1.72
72
429
89
498
2.16
7.70
3.0
2.0
3.0
2.8
mg/l
0.40
77
435
12
18
6.92
7.67
1.1
1.9
89.4
89.2
%
0.04
12
18
83
453
2.19
7.64
3.1
3.6
725.5
1105.1
ng/l
0.92
66
383
261
2238
3.72
7.23
15.6
11.4
21.5
21.4
mg/l
0.01
220
1715
76
415
2.14
6.91
2.0
1.7
437.5
19676964.6
pmol/l
0.50
63
371
62
313
2.26
6.83
2.0
1.7
1479.6
1140.4
nmol/l
1.44
46
240
12
21
5.93
6.64
1.2
2.0
1.9
1.6
mmol/l
0.45
12
21
200
1547
2.04
6.63
3.9
3.5
10.1
10.5
mm/h
0.19
191
1427
45
204
2.44
6.31
14.0
18.3
1.2
1.2
inr
—
5
31
153
1108
1.85
5.88
3.2
2.7
100.7
91.6
ug/l
0.32
142
1036
165
1225
1.85
5.84
5.2
9.2
4.2
4.1
e9/l
0.50
153
1070
112
738
1.87
5.81
2.2
1.9
97.3
94.6
pmol/l
0.22
59
419
107
696
1.87
5.78
3.1
2.9
—
—
—
0
0
31
124
2.69
5.60
1.7
1.6
—
—
—
0
0
76
447
1.96
5.52
1.7
1.4
23.6
20.7
nmol/l
0.69
65
385
131
923
1.79
5.35
4.6
7.0
1.2
1.2
mmol/l
0.60
103
785
243
2089
2.30
5.19
5.4
4.5
1.8
1.8
mu/l
0.50
221
1937
83
517
1.86
5.02
1.7
1.9
104.2
217.4
u/l
2.29
75
483
74
445
1.90
4.99
4.6
3.6
1.0
1.0
kg/l
0.70
11
64
43
212
2.22
4.96
8.3
5.7
—
—
—
0
0
49
259
2.08
4.74
2.1
2.3
27.5
24.4
%
0.52
41
229
12
29
4.28
4.67
2.9
2.7
4.7
4.6
e9/l
0.07
12
29
233
2001
2.02
4.52
6.8
4.8
39.5
38.7
mmol/mol
0.76
225
1893
80
508
1.81
4.49
1.3
1.2
6.0
2.2
u/ml
0.47
29
141
12
30
4.14
4.48
2.9
3.0
65.8
58.4
%
1.21
12
30
116
822
1.71
4.43
4.7
6.4
1.2
1.2
mmol/l
0.93
110
760
244
2147
2.12
4.16
5.3
3.8
5.9
5.8
mmol/l
1.36
226
1984
96
658
1.70
4.08
2.1
3.3
2.3
2.3
mmol/l
0.53
87
599
82
538
1.74
4.08
2.9
2.8
0.1
0.4
e6/l
2.88
73
396
18
64
2.94
4.04
2.0
1.4
37.9
39.9
nmol/l
0.14
18
64
59
356
1.83
3.87
1.5
1.2
37.0
26.6
iu/ml
0.25
18
106
118
864
1.64
3.84
2.5
2.2
73.4
73.4
nmol/l
0.01
109
794
71
458
1.74
3.71
1.7
1.6
0.9
1.1
mg/l
0.39
54
352
31
151
2.19
3.68
2.4
2.7
65.2
68.6
ml/min/173m2
0.14
13
66
25
112
2.35
3.60
1.6
1.4
—
—
—
0
0
100
712
1.63
3.59
3.2
3.1
29.4
30.7
u/l
0.27
90
688
52
310
1.83
3.53
2.1
2.2
13.8
14.2
umol/l
0.14
44
289
8
13
6.30
3.52
1.5
1.3
5.2
7.2
mmol/l
—
8
13
262
2421
2.43
3.13
11.7
8.8
25.9
25.5
u/l
0.18
255
2349
238
2136
1.79
2.97
13.1
10.2
85.9
86.6
ml/min/173m2
0.20
206
1726
34
187
1.93
2.95
1.7
1.7
—
—
—
0
0
23
109
2.21
2.94
1.2
1.5
—
—
—
0
0
71
490
1.60
2.82
2.4
2.6
348.4
8028.9
umol/l
2.69
64
437
18
78
2.40
2.81
1.7
1.7
—
—
—
0
0
22
105
2.19
2.77
2.5
5.1
1.0
1.6
mmol/l
0.31
16
82
192
1647
1.54
2.75
3.4
3.4
—
—
—
0
0
7
14
5.10
2.74
1.0
1.9
—
—
—
0
0
23
114
2.11
2.65
2.5
4.8
5.1
5.1
kpa
0.21
23
106
33
187
1.87
2.63
1.7
1.8
—
—
—
0
0
13
50
2.68
2.57
2.3
2.8
25.2
24.8
mmol/l
0.13
13
39
248
2279
1.82
2.50
5.4
4.2
2.8
2.8
mmol/l
0.11
232
2132
11
40
2.82
2.40
1.5
1.4
—
—
—
0
0
182
1566
1.47
2.39
4.2
2.8
46.1
43.7
u/l
0.19
170
1498
12
46
2.68
2.39
1.5
1.4
—
—
—
0
0
5
8
6.34
2.38
1.0
1.0
—
—
—
0
0
244
2240
1.73
2.36
5.0
3.8
1.4
1.5
mmol/l
2.00
228
2098
11
41
2.75
2.30
2.5
2.9
—
—
—
0
0
43
280
1.63
2.14
1.7
1.8
—
—
—
0
0
49
330
1.59
2.13
3.1
3.5
156.7
516.8
ng/l
0.78
31
238
238
2185
1.62
2.12
12.8
12.2
39.8
39.9
%
0.04
153
1716
31
185
1.76
2.12
1.1
1.3
129.6
164.3
iu/ml
0.16
11
79
19
96
2.05
2.11
6.4
7.4
24.0
24.2
mmol/l
0.11
19
89
48
324
1.58
2.07
1.4
1.2
1.1
8.0
u/ml
2.12
19
133
6
15
4.06
2.05
1.5
1.6
—
—
—
0
0
34
211
1.70
2.03
3.6
2.6
13.6
7.9
umol/l
0.49
28
181
24
134
1.87
2.03
2.0
2.2
17789.0
2527.3
u/l
—
6
65
243
2249
1.64
2.01
5.1
3.8
4.7
4.7
mmol/l
0.05
228
2116
5
11
4.61
1.95
1.2
1.0
—
—
—
0
0
24
136
1.84
1.94
2.5
2.2
2.1
9.6
ug/l
2.80
24
121
18
93
2.00
1.90
2.9
3.0
1.3
1.3
%
0.02
18
93
27
161
1.75
1.86
3.0
3.7
2.5
1.7
mmol/l
0.55
20
119
5
12
4.22
1.83
1.2
1.2
—
—
—
0
0
5
12
4.22
1.83
1.2
1.2
—
—
—
0
0
49
345
1.51
1.76
2.0
2.6
2.4
2.4
mmol/l
0.04
42
303
13
61
2.19
1.74
1.2
1.1
—
—
—
0
0
68
513
1.43
1.73
2.5
2.2
—
—
—
0
0
7
24
2.96
1.73
1.9
1.3
—
—
—
0
0
72
549
1.42
1.73
1.9
1.6
1.5
1.4
mmol/l
0.52
57
465
5
13
3.90
1.72
1.0
1.2
18410.0
655861.0
e6/l
—
5
8
13
62
2.15
1.68
1.2
1.1
—
—
—
0
0
26
160
1.69
1.62
3.0
3.7
5.7
5.6
kpa
0.22
26
155
8
32
2.54
1.61
1.1
1.1
—
—
—
0
0
233
2163
1.48
1.60
4.5
3.5
1.4
1.2
mmol/l
1.44
220
2025
21
124
1.75
1.52
1.4
1.4
—
—
—
0
0
11
52
2.16
1.46
2.4
5.8
8.7
8.6
kpa
0.11
11
47
5
16
3.16
1.44
1.2
1.9
12.5
14.9
ug/l
—
5
16
24
151
1.65
1.40
5.2
8.5
131.5
120.7
g/l
1.47
24
146
11
54
2.08
1.34
1.5
1.1
—
—
—
0
0
22
137
1.66
1.34
2.9
3.2
4.6
4.8
kpa
0.22
22
132
6
24
2.53
1.31
1.5
1.7
—
—
—
0
0
216
2003
1.35
1.28
15.5
14.0
13.6
13.6
%
0.00
209
1961
8
36
2.26
1.25
1.6
2.0
—
—
—
0
0
43
318
1.42
1.23
1.9
2.3
0.8
1.1
e6/l
0.37
30
175
5
19
2.66
1.22
1.0
1.1
—
—
—
0
0
14
79
1.81
1.19
1.1
1.5
—
—
—
0
0
61
482
1.34
1.18
4.8
4.2
20.2
21.0
%
0.20
29
225
8
39
2.08
1.16
1.4
1.8
—
—
—
0
0
17
103
1.69
1.15
5.5
11.9
93.4
93.8
%
0.13
17
103
5
21
2.41
1.09
3.8
3.8
2.7
3.3
nmol/l
—
5
21
7
32
2.22
1.09
1.4
1.3
—
—
—
0
0
7
33
2.15
1.06
1.4
1.5
—
—
—
0
0
7
34
2.09
1.03
3.1
1.9
13.5
13.1
%
—
7
34
10
53
1.92
1.02
1.4
1.7
—
—
—
0
0
10
55
1.85
0.93
1.4
1.7
—
—
—
0
0
6
29
2.09
0.90
1.3
1.7
—
—
—
0
0
11
64
1.75
0.87
1.9
2.1
5.4
0.3
ug/l
0.58
11
58
6
32
1.89
0.82
1.2
1.1
—
—
—
0
0
18
123
1.50
0.80
1.1
1.0
—
—
—
0
0
6
33
1.84
0.79
1.5
1.7
—
—
—
0
0
0
25
0.00
0.79
0.0
1.5
—
12.4
—
0
6
60
505
1.24
0.73
1.8
1.6
—
—
—
0
0
18
126
1.46
0.72
1.4
2.0
2.4
2.8
mg/l
0.15
12
88
5
26
1.94
0.71
1.0
1.3
—
—
—
0
0
29
227
1.31
0.63
1.2
1.5
—
—
—
0
0
8
49
1.65
0.62
1.3
1.2
—
—
—
0
0
5
30
1.68
0.61
1.0
1.7
6.8
7.8
mmol/l
—
5
18
0
20
0.00
0.60
0.0
3.0
—
—
—
0
0
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
10
64
1.58
0.59
1.5
1.9
—
—
—
0
0
8
54
1.50
0.58
1.3
1.2
—
—
—
0
0
6
36
1.68
0.57
1.2
1.4
—
—
—
0
0
10
65
1.56
0.56
2.7
6.5
24.1
25.0
mmol/l
—
10
65
6
38
1.59
0.54
1.5
1.7
—
—
—
0
0
13
93
1.42
0.49
1.5
1.5
132.9
237.3
miu/ml
—
5
46
28
228
1.25
0.47
6.0
4.0
32.5
31.9
%
0.14
22
147
13
94
1.40
0.47
1.5
1.7
—
—
—
0
0
5
31
1.62
0.43
1.4
1.7
—
—
—
0
0
39
335
1.19
0.41
1.9
2.0
—
—
—
0
0
0
15
0.00
0.41
0.0
2.7
—
—
—
0
0
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
43
377
1.17
0.37
1.9
2.1
—
—
—
0
0
7
54
1.30
0.30
1.1
1.0
—
—
—
0
0
8
108
0.73
0.29
1.3
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
6.3
—
0
10
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
32.4
—
0
5
0
12
0.00
0.21
0.0
1.0
—
24.5
—
0
12
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
5
43
1.17
0.21
1.2
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
11
132
0.83
0.18
1.4
1.4
—
—
—
0
0
11
132
0.83
0.18
1.4
1.4
—
—
—
0
0
11
132
0.83
0.18
1.4
1.4
—
—
—
0
0
11
132
0.83
0.18
1.4
1.4
—
—
—
0
0
7
58
1.21
0.18
1.1
1.5
—
—
—
0
0
5
67
0.74
0.17
2.0
1.7
—
0.0
—
0
14
5
69
0.72
0.17
1.8
1.7
—
—
—
0
0
8
73
1.10
0.16
1.1
1.1
—
8.3
—
0
14
52
493
1.07
0.13
1.5
1.5
—
—
—
0
0
10
89
1.13
0.07
1.6
1.7
—
—
—
0
0
37
355
1.05
0.06
3.3
2.9
0.6
0.8
ug/l
1.14
27
231
10
108
0.92
0.03
1.8
1.6
—
—
—
0
0
24
246
0.97
0.00
1.8
1.8
—
—
—
0
0
31
304
1.02
0.00
2.2
2.5
3.5
3.0
e6/l
0.13
17
162
11
108
1.02
0.00
1.6
1.7
—
—
—
0
0
14
138
1.02
0.00
1.4
1.5
—
—
—
0
0
19
193
0.98
0.00
1.8
1.7
—
—
—
0
0
28
277
1.01
0.00
1.5
1.6
—
—
—
0
0
17
166
1.03
0.00
1.4
1.5
—
—
—
0
0
7
76
0.92
0.00
1.7
1.8
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
11
110
1.00
0.00
1.3
1.4
—
—
—
0
0
8
82
0.97
0.00
4.9
3.8
25.5
23.9
mmol/l
—
8
75
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
224.8
—
0
6
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
7.8
—
0
5
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
5
52
0.96
0.00
1.0
1.2
—
9.0
—
0
13
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
7
70
1.00
0.00
1.4
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_DIASTASIS and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_DIASTASIS | 0.982 [0.75, 1.28] | 0.891 |
| Birth year | 0.99 [0.98, 1.0] | 0.051 |
During the follow-up period (1.1.1998 — 31.12.2019), 73 out of 493 males with M13_DIASTASIS died.
Mortality risk
Mortality risk for people of age
years, who have M13_DIASTASIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.197% |
| 5 | No data | 1.252% |
| 10 | No data | 3.111% |
| 15 | No data | 5.867% |
| 20 | No data | 10.226% |
Relationships between endpoints
↥Index endpoint: M13_DIASTASIS – Diastasis of muscle
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data